A detailed history of Geneos Wealth Management Inc. transactions in Cabot Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 74 shares of CBT stock, worth $6,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74
Holding current value
$6,848
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$86.96 - $111.73 $6,435 - $8,268
74 New
74 $8,000
Q1 2024

May 03, 2024

BUY
$71.14 - $92.2 $1,280 - $1,659
18 New
18 $1,000

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $5.21B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.